Donna M Evon

Dr. Evon is a clinical health psychologist, Professor of Medicine in the Division of GI and Hepatology at the University of North Carolina in Chapel Hill since 2005. She is a clinician and behavioral researcher in the field of chronic liver disease for 20 years. Clinically, she works with patients with MASLD/MASH to make lifestyle changes to improve liver health and achieve weight loss and with patients with cirrhosis and other liver diseases on coping, adjustment and self-management. Dr. Evon is also very passionate about patient-centered outcomes research.

Ravshan Yakubov

Ravshan Yakubov, MBA, CPA, CA is an accounting and finance professional who lives in Ottawa, Canada. Born and raised in Uzbekistan, Ravshan lived, worked and studied in Europe, the USA and Canada.

Chari Cohen

Chari Cohen is President of the Hepatitis B Foundation. She conducts research and implements programs to reduce health disparities and improve health outcomes associated with hepatitis B, hepatitis D and liver cancer. Dr. Cohen is co-chair of the Hep B United coalition, co-founder and chair of Hep B United Philadelphia, co-founder and chair of CHIPO: Coalition Against Hepatitis for People of African Origin.

Carolyn Wester

Dr. Carolyn Wester serves as the Director of the Division of Viral Hepatitis within CDC's National Center for HIV, Viral Hepatitis, STD, and TB Prevention. She has over 25 years of public health and clinical research experience focused on the prevention, diagnosis, and treatment of viral hepatitis, HIV, and STIs in the U.S. and internationally. In her current role, Dr.

Alina M. Allen

Alina M. Allen, M.D.,M.S. is Associate Professor of Medicine at Mayo Clinic in Rochester, Minnesota, where she serves as the Director of Hepatology and Director of the MASLD Clinic.

Veronica Miller

Veronica Miller PhD, Adjunct Professor at Berkeley Public Health, directs the Forum for Collaborative Research and its Data & Analysis Center. The Forum applies innovative translational medicine approaches to complex high-prevalence and rare diseases (steatotic/ cholestatic liver diseases, viral infections, ocular diseases) requiring multi-modal approaches to generate solutions. This involves multidisciplinary teams in Public Health, Medicine, Biology, Statistics, Computer Science, Data/Regulatory Science from academia, industry, governments and communities.

Neeraj Mistry

Dr. Mistry is a public health physician with wide ranging experience in HIV/AIDS and neglected tropical diseases having served as the Managing Director of the Global Network for Neglected Tropical Diseases. He brings extensive global health policy and programming experience having worked in both the public and private sectors, in clinical practice, health policy, and social development. Prior to accepting a position teaching at Georgetown University, he was engaged by the National Health Service in London, and with Merck & Co.

Tiffany Mensah

Tiffany Mensah is a public health educator and Program Coordinator at the Fatty Liver Foundation (FLF). In this role, she develops campaigns that promote behavior change and empower patients through accessible resources.

Before joining FLF, Tiffany worked as a Quality Assurance Analyst at Epic Systems, where she managed the development of infrastructure projects supporting a population health analytics application. She also gained experience as an intern with Empowerment Resource Center in Atlanta, GA, creating digital content to help combat HIV transmission.

Subscribe to